Vanguard Intermediate-Term Treasury Index ETF (NASDAQ:VGIT – Get Free Report) was the recipient of a significant drop in short interest in the month of November. As of November 30th, there was short interest totalling 1,120,000 shares, a drop of 26.3% from the November 15th total of 1,520,000 shares. Based on an average daily trading volume, of 2,779,500 shares, the days-to-cover ratio is presently 0.4 days.
Vanguard Intermediate-Term Treasury Index ETF Stock Down 0.3 %
VGIT stock opened at $58.43 on Friday. The business’s 50-day moving average price is $58.83 and its 200-day moving average price is $59.13. Vanguard Intermediate-Term Treasury Index ETF has a twelve month low of $57.03 and a twelve month high of $60.82.
Vanguard Intermediate-Term Treasury Index ETF Increases Dividend
The company also recently declared a monthly dividend, which was paid on Tuesday, November 5th. Shareholders of record on Friday, November 1st were issued a dividend of $0.1855 per share. The ex-dividend date was Friday, November 1st. This represents a $2.23 annualized dividend and a yield of 3.81%. This is an increase from Vanguard Intermediate-Term Treasury Index ETF’s previous monthly dividend of $0.18.
Hedge Funds Weigh In On Vanguard Intermediate-Term Treasury Index ETF
Vanguard Intermediate-Term Treasury Index ETF Company Profile
Vanguard Intermediate Term Government Bond ETF (the Fund) seeks to track the performance of a market-weighted government bond index with an intermediate-term, dollar-weighted average maturity. The Fund employs a passive management or indexing investment approach designed to track the performance of the Barclays Capital U.S.
Recommended Stories
- Five stocks we like better than Vanguard Intermediate-Term Treasury Index ETF
- Consumer Discretionary Stocks Explained
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- 3 Fintech Stocks With Good 2021 Prospects
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Vanguard Intermediate-Term Treasury Index ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vanguard Intermediate-Term Treasury Index ETF and related companies with MarketBeat.com's FREE daily email newsletter.